Zobrazeno 1 - 10
of 93
pro vyhledávání: '"M. H. J. Van Oers"'
Autor:
L. F. Verdonck, A. Beeker, Jan J. Cornelissen, Matthijs Westerman, M. Hoogendoorn, Wendimagegn Ghidey Alemayehu, Marcel Nijland, Eefke Petersen, O. de Weerdt, Pierre Zachee, Martine E.D. Chamuleau, M. van Gelder, Arnon P. Kater, Gert Jan Timmers, Martine C. J. Abrahamse-Testroote, M. H. J. Van Oers
Publikováno v:
van Gelder, M, van Oers, M H, Alemayehu, W G, Abrahamse-Testroote, M C J, Cornelissen, J J, Chamuleau, M E, Zachee, P, Hoogendoorn, M, Nijland, M, Petersen, E J, Beeker, A, Timmers, G-J, Verdonck, L, Westerman, M, de Weerdt, O & Kater, A P 2016, ' Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study ', Bone Marrow Transplantation, vol. 51, no. 6, pp. 799-806 . https://doi.org/10.1038/bmt.2016.9
Bone Marrow Transplantation, 51(6), 799-806. Nature Publishing Group
Bone marrow transplantation, 51(6), 799-806. Nature Publishing Group
Bone Marrow Transplantation, 51(6), 799-806. Nature Publishing Group
Bone marrow transplantation, 51(6), 799-806. Nature Publishing Group
Allogeneic stem cell transplantation (alloSCT) remains the only curative option for CLL patients. Whereas active disease at the time of alloSCT predicts poor outcome, no standard remission-induction regimen exists. We prospectively assessed outcome a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::981d05b2626afd866454551521461c36
https://hdl.handle.net/11370/85d0bf27-7708-4117-86d3-7c1dbd63e264
https://hdl.handle.net/11370/85d0bf27-7708-4117-86d3-7c1dbd63e264
Autor:
M. G. M. Kok, A. H. Zwinderman, K. de Heer, Caroline E. Visser, M P van der Schee, P. J. Sterk, Els J.M. Weersink, M. H. J. Van Oers, Niki Fens
Publikováno v:
Journal of clinical microbiology, 54(3), 569-575. American Society for Microbiology
Currently, there is no noninvasive test that can reliably diagnose early invasive pulmonary aspergillosis (IA). An electronic nose (eNose) can discriminate various lung diseases through an analysis of exhaled volatile organic compounds. We recently p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32a5f13290f4b8b7e131c8022b4e8869
https://doi.org/10.1128/jcm.02214-15
https://doi.org/10.1128/jcm.02214-15
Autor:
C.A. Uyl-de Groot, Z. Erjavec, E. (Vera) J. M. Mattijssen, Gerard Vreugdenhil, Kim M. Holtzer-Goor, Eduardus F. M. Posthuma, Simon Daenen, Peter C. Huijgens, P. W. Wijermans, W. G. Peters, H. Visser, M. R. Schaafsma, P. Joosten, S. Wittebol, M. H. J. Van Oers, K. G. van der Hem
Publikováno v:
Quality of Life Research, 24(12), 2895-2906. Springer Netherlands
Quality of Life Research, 24(12), 2895-2906. SPRINGER
Holtzer-Goor, K M, Schaafsma, M R, Joosten, P, Posthuma, E F M, Wittebol, S, Huijgens, P C, Mattijssen, E J M, Vreugdenhil, G, Visser, H, Peters, W G, Erjavec, Z, Wijermans, P W, Daenen, S M G J, van der Hem, K G, van Oers, M H J & Uyl-de Groot, C A 2015, ' Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study ', Quality of Life Research, vol. 24, no. 12, pp. 2895-2906 . https://doi.org/10.1007/s11136-015-1039-y
Quality of Life Research, 24(12), 2895-2906. Springer, Cham
Quality of Life Research
Quality of life research, 24(12), 2895-2906. Springer Netherlands
Quality of Life Research, 24(12), 2895-2906. SPRINGER
Holtzer-Goor, K M, Schaafsma, M R, Joosten, P, Posthuma, E F M, Wittebol, S, Huijgens, P C, Mattijssen, E J M, Vreugdenhil, G, Visser, H, Peters, W G, Erjavec, Z, Wijermans, P W, Daenen, S M G J, van der Hem, K G, van Oers, M H J & Uyl-de Groot, C A 2015, ' Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study ', Quality of Life Research, vol. 24, no. 12, pp. 2895-2906 . https://doi.org/10.1007/s11136-015-1039-y
Quality of Life Research, 24(12), 2895-2906. Springer, Cham
Quality of Life Research
Quality of life research, 24(12), 2895-2906. Springer Netherlands
Purpose To describe the health-related quality of life (HRQoL) of an unselected population of patients with chronic lymphocytic leukaemia (CLL) including untreated patients. Methods HRQoL was measured by the EORTC QLQ-C30 including the CLL16 module,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c7058cbb1613db4d1a60c05ddf2daf4
https://doi.org/10.1007/s11136-015-1039-y
https://doi.org/10.1007/s11136-015-1039-y
Autor:
S. M. Ansell, Ranjana H. Advani, Bertrand Coiffier, Yusri Elsayed, Patrick Hilden, Kenichi Takeshita, Stephen J. Schuster, Massimo Federico, Jürgen Rademaker, Franck Morschhauser, Igor Aurer, Gilles Salles, Nathan Fowler, Lawrence H. Schwartz, John Kuruvilla, Laurie H. Sehn, Catherine Fortpied, Andreas Engert, John G. Gribben, Venkatraman E. Seshan, Richard F. Little, Mitchell R. Smith, S. de Vos, Catherine M. Bollard, John F. Seymour, Jeremy S. Abramson, Martin Hutchings, Ahmed I. Younes, Kensei Tobinai, Martin Dreyling, Richard I. Fisher, Mark S. Kaminski, Kara M. Kelly, Marek Trneny, Michel Meignan, Andre Goy, Andrew D. Zelenetz, Ioana Kloos, Walter R. Wilson, Ajay K. Gopal, T. E. Witzig, John P. Leonard, Catherine Thieblemont, Nancy Valente, M. H. J. Van Oers, M Pfreunschuh, Anton Hagenbeek, Simon Rule, Pier Luigi Zinzani, Heiko Schöder
Publikováno v:
Annals of Oncology
Annals of Oncology, Oxford University Press (OUP), 2017, 28 (7), pp.1436-1447
Annals of Oncology, Oxford University Press (OUP), 2017, 28 (7), pp.1436-1447
International audience; In recent years, the number of approved and investigational agents that can be safely administered for the treatment of lymphoma patients for a prolonged period of time has substantially increased. Many of these novel agents a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa0c8715bbf7742527007c73e0ae6b4f
https://pubmed.ncbi.nlm.nih.gov/28631736
https://pubmed.ncbi.nlm.nih.gov/28631736
Autor:
Eric Eldering, Arnon P. Kater, Annemieke Kuil, M H Jansen, M F M de Rooij, Marie-Jose Kersten, J ter Burg, Marcel Spaargaren, Rachel Thijssen, Joke W. Baars, A Virone-Oddos, G G W van Bochove, Coumaran Egile, Taco W. Kuijpers, M. H. J. Van Oers
Publikováno v:
Leukemia, 30(2), 337-345. Nature Publishing Group
The phosphoinositide 3-kinases (PI3Ks) are critical components of the B-cell receptor (BCR) pathway and have an important role in the pathobiology of chronic lymphocytic leukemia (CLL). Inhibitors of PI3Kδ block BCR-mediated cross-talk between CLL c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48d33395b736e28ede55ca7b3900ea00
https://pure.amc.nl/en/publications/the-pan-phosphoinositide-3kinasemammalian-target-of-rapamycin-inhibitor-sar245409-voxtalisibxl765-blocks-survival-adhesion-and-proliferation-of-primary-chronic-lymphocytic-leukemia-cells(e1dd5979-78b3-41b1-b9ae-627cb907c11e).html
https://pure.amc.nl/en/publications/the-pan-phosphoinositide-3kinasemammalian-target-of-rapamycin-inhibitor-sar245409-voxtalisibxl765-blocks-survival-adhesion-and-proliferation-of-primary-chronic-lymphocytic-leukemia-cells(e1dd5979-78b3-41b1-b9ae-627cb907c11e).html
Autor:
Els J.M. Weersink, Caroline E. Visser, K. de Heer, M. H. J. Van Oers, Niki Fens, M. G. M. Kok, M P van der Schee, A. H. Zwinderman, P. J. Sterk
Publikováno v:
Journal of clinical microbiology. 54(7)
Currently, there is no noninvasive test that can reliably diagnose early invasive pulmonary aspergillosis (IA). An electronic nose (eNose) can discriminate various lung diseases through an analysis of exhaled volatile organic compounds. We recently p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5578b46badc390691ac9a89251fb06b1
https://doi.org/10.1128/jcm.00748-16
https://doi.org/10.1128/jcm.00748-16
Autor:
David Gonzalez, John G. Gribben, Emili Montserrat, Jitka Malčíková, Stephan Stilgenbauer, Hartmut Döhner, Davide Rossi, Arnon P. Kater, Šárka Pospíšilová, Thorsten Zenz, Florence Cymbalista, Paolo Ghia, Michael Hallek, M. H. J. Van Oers, Barbara Eichhorst, Peter Hillmen, Martin Trbušek
Publikováno v:
Leukemia. 26(7):1458-1461
Recent evidence suggests that - in addition to 17p deletion - TP53 mutation is an independent prognostic factor in chronic lymphocytic leukemia (CLL). Data from retrospective analyses and prospective clinical trials show that similar to 5% of untreat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d8964c255b5c79fdc268c4924512c3
https://doi.org/10.1038/leu.2012.25
https://doi.org/10.1038/leu.2012.25
Autor:
Robert Foa, C M Wendtner, M. H. J. Van Oers, Marco Montillo, Claire Dearden, T. S. Lin, Anders Österborg, Christian H. Geisler, Martin J. S. Dyer, R. F. Bezares, Kanti R. Rai
Publikováno v:
Leukemia. 23(11):1980-1988
The consensus views of an expert roundtable meeting are presented as updated management guidelines for using alemtuzumab in chronic lymphocytic leukemia. Since the publication of previous management guidelines in 2004, clinical experience with alemtu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1c4f1c852ac8cff9e31e635d1b874d2
https://doi.org/10.1038/leu.2009.146
https://doi.org/10.1038/leu.2009.146
Autor:
Anna Skowronska, Arnon P. Kater, H. Yigittop, Dieuwertje M. Luijks, M. Loden-van Straaten, E. Eldering, Tatjana Stankovic, Martin Trbušek, Veronika Navrkalová, Thorsten Zenz, N. Laddach, Perry D. Moerland, Ingrid A. M. Derks, Mels Hoogendoorn, M. H. J. Van Oers, Alexander C. Leeksma, G.D. te Raa
Publikováno v:
Cell Death & Disease
Cell death & disease, 6. Nature Publishing Group
Cell death & disease, 6. Nature Publishing Group
The ATM-p53 DNA-damage response (DDR) pathway has a crucial role in chemoresistance in CLL, as indicated by the adverse prognostic impact of genetic aberrations of TP53 and ATM. Identifying and distinguishing TP53 and ATM functional defects has becom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d21d671ce948393763735613eff02e7
https://doi.org/10.1038/cddis.2015.223
https://doi.org/10.1038/cddis.2015.223
Autor:
Jitka Malčíková, G.D. te Raa, E. Eldering, Hanneke N. Monsuur, Arnon P. Kater, Alexander Jethwa, Tatjana Stankovic, Ingrid A. M. Derks, Veronika Navrkalová, Šárka Pospíšilová, M. Lodén, Ceri E. Oldreive, Perry D. Moerland, Anna Skowronska, M. H. J. Van Oers, Thorsten Zenz, J van Laar, Martin Trbušek, Christian H. Geisler, Jennifer Hüllein
Publikováno v:
Leukemia, 29(5), 1133-1142. Nature Publishing Group
Leukemia
Leukemia
Mutations or deletions in TP53 or ATM are well-known determinants of poor prognosis in chronic lymphocytic leukemia (CLL), but only account for approximately 40% of chemo-resistant patients. Genome-wide sequencing has uncovered novel mutations in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09caaa3f2be2285402c3f5ed97e53912
https://pure.amc.nl/en/publications/the-impact-of-sf3b1-mutations-in-cll-on-the-dnadamage-response(239e4aef-b5c8-427e-8fb7-f6b090758a1f).html
https://pure.amc.nl/en/publications/the-impact-of-sf3b1-mutations-in-cll-on-the-dnadamage-response(239e4aef-b5c8-427e-8fb7-f6b090758a1f).html